Study of exposure and vaccination coverage of the medical students
- VernacularTitle:АШУҮИС-ийн оюутнуудын ковид-19 халдварт өртсөн байдал ба вакцин хамрагдалтын судалгаа
- Author:
Yanjindulam B
1
;
Naranzul B
1
;
Ulziisuren B
1
;
Byambasuren S
1
;
Gantsetseg G
1
;
Solongo G
1
;
Narangerel P
2
;
Nyammkhuu D
3
;
Nyamsuren B
3
;
Munkhzul D
3
;
Batchimeg Ch
2
;
Ganchimeg Ch
2
;
Oyunbileg D
4
;
Khosbayar T
2
,
3
Author Information
1. Postgraduate Institute, MNUMS
2. School of Medicine, Department of Clinical Laboratory, MNUMS
3. Clinical Molecular Diagnostic Center, MNUMS
4. Student Affairs, MNUMS
- Publication Type:Journal Article
- From:
Diagnosis
2023;106(3):109-117
- CountryMongolia
- Language:Mongolian
-
Abstract:
Background:To prevent and combat the spread of the COVID-19 pandemic, the Government of Mongolia has implemented measures such as movement and time restrictions, social distancing and isolation, closure of schools, kindergartens and public places, immunization, and others. It has caused adverse consequences for people, social relations, and the economy, causing health, social, economic, and humanitarian crises. Not only does this situation, medical students, as frontline healthcare workers, are more susceptible to virus infection. Vaccines against COVID-19 have been researched quickly due to the pandemic and are being used under emergency use authorization. In our country the approach of mixing vaccine doses from different manufacturers was used (fractional doses). Therefore, there is no study on the exposure of medical students to the COVID-19 infection and the adverse effects after receiving a dose of a heterologous vaccine. Objective: To study the exposure to the COVID-19 infection and vaccination status of medical students.
Methods:The survey was conducted from November 2023 to December 2023 using a cross-sectional study design, and 170 students who study at ASUSU and live in the dormitory were included.
Results:A total of 170 students participated in the study. 55.9% (n=95) of them were in the first year, 22.4% (n=38) were in the second year, 10% (n=17) were in the third year, 7.6% (n=13) were in the fourth year, 2.4% (n=4) were from the 5th year and 1.8% (n=3) were from the 6th year students. 88.2% (n=150) of students were female and 11.8% (n=20) were male. In this study, 37.1% of the students were infected by COVID-19 infection previously. Among them, 50% of the students were infected from family members, 16.7% from the school environment, and 15.2% did not know about the source of infection. 76.2% of the respondents were diagnosed with COVID-19 in a medical institution, and forty-one students answered that they were treated at the hospital. 83% of the cases were treated at home and were cured within 14 days. In contrast, 93.8% of the hospitalized students were treated within four months to 1 year. The current study demonstrates neurological, respiratory, sensory, cardiovascular, psychiatric, digestive, and dermatological symptoms were in 37.6%, 24.1%, 27.6%, 17.6%, 11.8%, 11.2%, and 10% of the students who participated in the study, respectively. For a year or more, symptoms of all organ systems were present, but neurological symptoms appeared to be the highest. 55.9% (n=115) of the enrolled students received 3 or 4 doses of the vaccine, 3.5% (n=6) did not receive the vaccine. In total, 35% (n=60) of the enrolled students experienced side effects and 65% (n=106) had no side effects.
Conclusion:In this study, 37.1% of the students were infected by COVID-19 infection previously. According to the current study, symptoms related to the nervous system was the most prevalent and 55.9% (n=115) of the enrolled students received 3 or 4 doses of the vaccine. In total, 35% (n=60) of the enrolled students experienced side effects.
- Full text:2025052715194634487Diagnosis-2023-106(3)-109-117.pdf
